Filing Flows › GeoVax Labs (GOVX) › Q2 2025 › vs Q2 2024
GeoVax Labs (GOVX) Q2 2025 vs Q2 2024 (year over year)
GeoVax Labs's revenue rose $552K (+183%) from $301K in Q2 2024 to $852K in Q2 2025.
GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart draws each line against Q2 2024, the increases inside each band.
Every line
| Line | Q2 2025 | Q2 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $852K | $301K | $552K | +183% |
| Other income, net | $49K | −$2K | $51K | — |
| Net loss | $5.4M | $5.1M | $306K | +6% |
| Costs & expenses | $6.3M | $5.4M | $906K | +17% |
| Operating costs | $6.3M | $5.4M | $908K | +17% |
| Research & development | $4.7M | $4.3M | $452K | +11% |
| General & admin | $1.5M | $1.1M | $456K | +42% |
| Operating cash sources | $5.4M | $5.1M | $306K | +6% |
| Depreciation & amortization | $17K | $24K | −$7K | -29% |
| Share-based compensation | $293K | $102K | $191K | +188% |
| Working capital & other | $726K | $3.0M | −$2.3M | -76% |
| Cash used in operations | $4.3M | $1.9M | $2.4M | +123% |
| Net loss absorbed | $5.4M | $5.1M | $306K | +6% |
Questions
How much did GeoVax Labs's revenue grow year over year in Q2 2025?
GeoVax Labs's revenue rose $552K (+183%) from $301K in Q2 2024 to $852K in Q2 2025.